Fig. 5From: Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trialMean changes from baseline in the percentage of migraine attacks that were severe (MMRM; efficacy analysis set). BL, baseline; Epti, eptinezumab; LS, least squares; MMRM, mixed model for repeated measuresBack to article page